التداخل بين أملوديبين وأولميسارتان وأرمودافينيل

There was also a slightly greater proportion of patients on NUVIGIL requiring new or increased use of antihypertensive medications (2.9%) compared to patients on placebo (1.8%).

Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.

CYP3A Inducers: No information is available on the quantitative effects of CYP3A inducers on amlodipine.